$AMWL Cashflow Statement | Understand Stock

$AMWL

$13.59 +$0.05 (0.37%) Close

$AMWL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Goodwill impairment
Investment impairment
Depreciation and amortization expense
Provisions for credit losses
Inventory provisions
Net gain on divestiture
Amortization of deferred contract acquisition costs
Amortization of deferred contract fulfillment costs
Noncash compensation costs incurred by selling shareholders
Accretion of discounts on debt securities
Interest on debt securities
Stock-based compensation expense
Loss on equity method investment
Deferred income taxes

Changes in operating assets and liabilities, net of acquisition:
Accounts receivable
Inventories
Deferred contract acquisition costs
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued expenses and other current liabilities
Other long-term liabilities
Deferred revenue

Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Capitalized software development costs
Investment in less than majority owned joint venture
Net proceeds from divestiture
Purchases of investments
Proceeds from sales and maturities of investments
Acquisitions of business, net of cash acquired
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from exercise of common stock options
Proceeds from employee stock purchase plan
Payments for the purchase of treasury stock
Proceeds from Section 16(b) disgorgement
Payment of contingent consideration
Payment of deferred offering costs
Net cash provided by financing activities

Effect of exchange rates changes on cash, cash equivalents, and restricted cash
Net decrease in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash at end of period
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Supplemental disclosure of non-cash investing and financing activities:
Issuance of common stock in acquisitions
Issuance of common stock in settlement of earnout
Receivable related to exercise of common stock options
Cash, cash equivalents, and restricted cash at end of period:
Cash and cash equivalents
Restricted cash

Comments